Recommendations on Use of Biomarkers in Alcoholism Treatment Trials

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 10, 2003, Pages 1667-1670

  Allen, John P ^a,c   Litten, Raye Z ^b  

^a Natl Inst Alcohol Abuse/Alcoholism   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c NONE   (United States)

Author keywords

Biochemical Measures; Biomarkers; Research Design; Treatment Outcome Measures

Indexed keywords

BIOCHEMICAL MARKER;

ACCURACY; ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG SAFETY; HUMAN; METHODOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SELF REPORT; TREATMENT OUTCOME;

ALCOHOLISM; BIOLOGICAL MARKERS; CLINICAL TRIALS; HEALTH PLANNING GUIDELINES; HUMANS; TREATMENT OUTCOME;

EID: 0142040215     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000091224.78880.47     Document Type: Conference Paper

References (10)

1. Allen JP, Fertig JB, Litten RZ, Sillanaukee P, Anton RF (1997) Proposed recommendations for research on biochemical markers of alcohol consumption. Alcohol Clin Exp Res 21:244-247.
2. Allen JP, Litten RZ (2001) The role of laboratory tests in alcoholism treatment. J Subst Abuse Treat 20:81-85.
3. Allen JP, Litten RZ, Fertig JB, Sillanaukee P (2001a) Carbohydrate-deficient transferrin: an aid to early recognition of alcohol relapse. Am J Addict 10(Suppl):24-28.
4. Allen JP, Litten RZ, Strid N, Sillanaukee P (2001b) The role of biomarkers in alcoholism medication trials. Alcohol Clin Exp Res 25:1119-1125.
5. Bean P, DeBruin T, Harasymiw J, Hallinan P (2002) New applications of contemporary biomarkers of alcohol consumption. Am Clin Chem 21: 19-21.
6. Burke V, Puddey IB, Rakic V, Swanson NR, Dimmitt SB, Beilin SB, Ching S, Beilby JP (1998) Carbohydrate-deficient transferrin as a marker of change in alcohol intake in men drinking 20 to 60 g of alcohol per day. Alcohol Clin Exp Res 22:1973-1980.
7. Huseby NE, Bjordal E, Nilssen O, Barth T (1997) Utility of biological markers during outpatient treatment of alcohol-dependent subjects: carbohydrate-deficient transferrin responds to moderate changes in alcohol consumption. Alcohol Clin Exp Res 21:1343-1346.
8. Mundle G, Ackermann K, Gunthner A, Munkes J, Mann K (1999) Treatment outcome in alcoholism - a comparison of self-report and the biological markers carbohydrate-deficient transferrin and gamma-glutamyl transferase. Eur Addict Res 5:90-96.
9. Randell E, Diamandis EP, Goldberg DM (1998) Changes in serum carbohydrate-deficient transferrin and gammaglutamyl transferase after moderate wine consumption in healthy males. J Clin Lab Anal 12:92-97.
10. Sillanaukee P, Massot N, Jousilahti P, Vartiainen E, Poikolainen K, Olsson U, Alho H (2000) Enhanced clinical utility of gamma-CDT in a general population. Alcohol Clin Exp Res 24:1202-1206.